Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.

Clinical lung cancer - 1 Mar 2014

Bar Jair, Damianovich Maya, Hout Siloni Goni, Dar Erel, Cohen Yoram, Perelman Marina, Ben Nun Alon, Simansky David, Yellin Alon, Urban Damien, Onn Amir

Abstract excerpt

BACKGROUND: Testing for genetic abnormalities in epithelial growth factor receptor (EGFR), anaplastic lymphoma receptor tyrosine kinase (ALK), and potentially additional genes is a critical tool in the care of advanced NSCLC. There is conflicting evidence for the role of such tests in early NSCLC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Neoplasm Staging

Share to Phosphatidylinositol 3-Kinases

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Survival Rate

Source

Identifiers

PMID: 24370118
DOI: 10.1016/j.cllc.2013.11.005

Genes

EGFR
KRAS
ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24370118-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.PMID 24370118Read ↗

Diagnostic Mutation Profiling and Validation of Non-Small-Cell Lung Cancer Small Biopsy Samples using a High Throughput Platform.Semantic proximity Read ↗

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.Semantic proximity Read ↗

Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.Semantic proximity Read ↗

Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.Semantic proximity Read ↗

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.Semantic proximity Read ↗

Genetic predictors of MEK dependence in non-small cell lung cancer.Semantic proximity Read ↗

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.Semantic proximity Read ↗

Common and rare EGFR and KRAS mutations in a Dutch non-small-cell lung cancer population and their clinical outcome.Semantic proximity Read ↗

Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer.Semantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.Semantic proximity Read ↗

Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.Semantic proximity Read ↗

Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.